MyAverix Finance
SHG · Healthcare
Ningbo Menovo Pharm Co Ltd (603538)
Drug Manufacturers - Specialty & Generic
Ningbo Menovo Pharm Co Ltd (603538) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $8.64B, P/E ratio is 18.00, net margin is 6.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603538
Ningbo Menovo Pharm Co Ltd (603538) — FAQ
What is Ningbo Menovo Pharm Co Ltd's market cap?
Ningbo Menovo Pharm Co Ltd (603538) has a reported market cap of $8.64B (data as of 2026-03-29).
What is 603538's P/E ratio?
The price-to-earnings (P/E) ratio for Ningbo Menovo Pharm Co Ltd (603538) is 18.00 (data as of 2026-03-29).
Does Ningbo Menovo Pharm Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Ningbo Menovo Pharm Co Ltd (603538). Check the MyAverix Finance app for the latest dividend data.
What sector is Ningbo Menovo Pharm Co Ltd in?
Ningbo Menovo Pharm Co Ltd (603538) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 603538 listed on?
603538 is listed on SHG.
What is Ningbo Menovo Pharm Co Ltd's net margin?
Ningbo Menovo Pharm Co Ltd (603538) reports a net margin of 6.5% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.